We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OPRX market cap is 94.13M. The company's latest EPS is USD -0.9536 and P/E is -5.35.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.33M | 28.37M | 19.69M | 18.81M | 21.31M |
| Operating Income | -3.55M | -8.76M | -5.03M | -3.75M | -8.56M |
| Net Income | -2.87M | -4.14M | -6.9M | -4.01M | -9.12M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 24.6M | 43.31M | 61.29M | 62.45M | 71.52M |
| Operating Income | -3.69M | -2.14M | 361k | -12.29M | -24.26M |
| Net Income | -3.14M | -2.21M | 378k | -11.44M | -17.57M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 123.93M | 183.37M | 176.37M | 172.88M | 165.2M |
| Total Liabilities | 7.82M | 56.82M | 53.83M | 51.86M | 50.73M |
| Total Equity | 116.11M | 126.55M | 122.54M | 121.02M | 114.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 56.64M | 60.33M | 140.99M | 134.65M | 183.37M |
| Total Liabilities | 11.78M | 10.35M | 9.61M | 8.54M | 56.82M |
| Total Equity | 44.86M | 49.97M | 131.38M | 126.11M | 126.55M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -982k | -7.24M | 2.12M | 2.9M | 4.69M |
| Investing | 664k | -25.34M | -153k | -238k | -330k |
| Financing | -7.97M | 28.22M | -640k | -1.56M | -2.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.66M | -6.31M | 726k | 10.65M | -7.24M |
| Investing | -10.58M | -125k | -486k | -58.18M | -25.34M |
| Financing | 22.18M | -1.9M | 73.93M | -18.95M | 28.22M |
| Market Cap | 94.13M |
| Price to Earnings Ratio | -5.35 |
| Price to Sales Ratio | 1.31 |
| Price to Cash Ratio | 6.78 |
| Price to Book Ratio | 0.74 |
| Dividend Yield | - |
| Shares Outstanding | 18.42M |
| Average Volume (1 week) | 101.95k |
| Average Volume (1 Month) | 119.63k |
| 52 Week Change | -66.02% |
| 52 Week High | 16.645 |
| 52 Week Low | 3.78 |
| Spread (Intraday) | 1.5 (22.9%) |
| Company Name | OptimizeRx Corporation |
| Address |
4955 s. durango dr las vegas, nevada 89113 |
| Website | https://www.optimizerx.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
